Literature DB >> 3771852

Effects of all-trans-retinoic acid on the dermis of hairless mice.

L H Kligman.   

Abstract

The marked degradative changes induced in human and animal dermis by chronic ultraviolet radiation are thought to be irreversible. We have shown in studies with hairless mice that a new normal dermis formed subepidermally after irradiation ceased. Because retinoids stimulate wound repair, we evaluated the ability of all-trans-retinoic acid (RA) to enhance the repair of ultraviolet damage. To produce mild dermal damage, hairless mice were irradiated for 10 weeks with FS20 sunlamps. The mice were then treated topically with various concentrations of RA for either 5 or 10 weeks. The skin was examined by light and electron microscopic techniques. The subepidermal repair zone in RA-treated mice was significantly wider than that in the untreated control group. The greater repair appeared to be retinoid specific and was dose dependent. The collagen was both histochemically and ultrastructurally normal; fibroblasts were numerous and morphologically hyperactive. In addition, topical RA increased dermal vascularity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3771852     DOI: 10.1016/s0190-9622(86)70234-x

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  18 in total

1.  Inhibition of type I procollagen synthesis by damaged collagen in photoaged skin and by collagenase-degraded collagen in vitro.

Authors:  J Varani; D Spearman; P Perone; S E Fligiel; S C Datta; Z Q Wang; Y Shao; S Kang; G J Fisher; J J Voorhees
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

2.  Decreased collagen production in chronologically aged skin: roles of age-dependent alteration in fibroblast function and defective mechanical stimulation.

Authors:  James Varani; Michael K Dame; Laure Rittie; Suzanne E G Fligiel; Sewon Kang; Gary J Fisher; John J Voorhees
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

Review 3.  Medicine in the elderly.

Authors:  P Diggory; A Homer; J Liddle; C F Pratt; S Samadian; R Tozer; C Weinstein
Journal:  Postgrad Med J       Date:  1991-05       Impact factor: 2.401

4.  MDI 301, a non-irritating retinoid, induces changes in human skin that underlie repair.

Authors:  James Varani; Kevin Fay; Patricia Perone
Journal:  Arch Dermatol Res       Date:  2006-12-05       Impact factor: 3.017

Review 5.  The role of topical retinoids in the treatment of photoaging.

Authors:  Alexander J Stratigos; Andreas D Katsambas
Journal:  Drugs       Date:  2005       Impact factor: 9.546

6.  Inhibition of epithelial cell adhesion by retinoic acid. Relationship to reduced extracellular matrix production and alterations in Ca2+ levels.

Authors:  J Varani; D F Gibbs; D R Inman; B Shah; S E Fligiel; J J Voorhees
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

7.  All-trans retinoic acid (RA) stimulates events in organ-cultured human skin that underlie repair. Adult skin from sun-protected and sun-exposed sites responds in an identical manner to RA while neonatal foreskin responds differently.

Authors:  J Varani; P Perone; C E Griffiths; D R Inman; S E Fligiel; J J Voorhees
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

8.  Retinoic acid stimulation of human dermal fibroblast proliferation is dependent on suboptimal extracellular Ca2+ concentration.

Authors:  J Varani; J Shayevitz; D Perry; R S Mitra; B J Nickoloff; J J Voorhees
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

9.  Evaluation of topical retinoids for cutaneous pharmacological activity in Yucatan microswine.

Authors:  G J Gendimenico; F T Liebel; J A Fernandez; J A Mezick
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

10.  Effects of all-trans retinoic acid and Ca++ on human skin in organ culture.

Authors:  J Varani; S E Fligiel; L Schuger; P Perone; D Inman; C E Griffiths; J J Voorhees
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.